Arcellx

Arcellx Dividend Yield

Delisted

Dividend Yield of Arcellx (ACLX) as of Oct 17, 2026.

Dividend Yield

-

Last updated:

Dividend Yield of Arcellx is 2026 - . Dividend Yield of Arcellx was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcellx Stock analysis

What does Arcellx do? Arcellx Inc, headquartered in Gaithersburg, US, is a clinical-stage biotechnology company focused on developing innovative cell therapies for cancer and other incurable diseases. The company, listed on February 4, 2022, operates with 209 employees and is advancing its lead program CART-ddBCMA in a pivotal Phase II trial for relapsed or refractory multiple myeloma. It also develops two clinical-stage ARC-SparX programs targeting BCMA and CD123 in various hematological malignancies. Arcellx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcellx stock

On Eulerpool you can find the complete historical development of Dividend Yield Arcellx since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's Arcellx historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Arcellx

All Key Metrics — Arcellx